Commodore Capital LP
Source: SEC Form 13F · as of Mar 2026Commodore Capital LP holds 21 biotech & pharma companies tracked by BioSniper, totaling $1.05B in value as of Mar 2026 (SEC Form 13F).
Companies held
21
Total value held
$1.05B
BioSniper AIPage evidence connected
Prepared research question
What matters most for Relay Therapeutics, Inc. (RLAY)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| RLAYRelay Therapeutics, Inc. | 17,000,000 | $169.2M |
| ELVNEnliven Therapeutics, Inc. | 3,275,000 | $128.4M |
| COGTCogent Biosciences, Inc. | 2,888,007 | $111.2M |
| SYRESpyre Therapeutics, Inc. | 1,912,380 | $96.5M |
| CLDXCelldex Therapeutics, Inc. | 2,696,616 | $85.5M |
| NUVLNuvalent, Inc. | 833,600 | $85.4M |
| PHVSPharvaris N.V. | 1,918,970 | $54.2M |
| DMRADamora Therapeutics, Inc. | 1,939,000 | $50.2M |
| DFTXDefinium Therapeutics Inc. | 2,000,000 | $37.8M |
| LBRXLB PHARMACEUTICALS INC | 1,500,000 | $37.0M |
| NRIXNurix Therapeutics, Inc. | 2,275,000 | $35.3M |
| ASMBASSEMBLY BIOSCIENCES, INC. | 1,000,000 | $27.8M |
| CATXPerspective Therapeutics, Inc. | 6,336,782 | $26.4M |
| SLNOSOLENO THERAPEUTICS INC | 652,432 | $21.8M |
| OCULOCULAR THERAPEUTIX, INC | 2,575,000 | $21.8M |
| ZURAZura Bio Ltd | 3,250,000 | $19.3M |
| SABSSAB BIOTHERAPEUTICS, INC. | 4,401,500 | $16.9M |
| ANTXAN2 Therapeutics, Inc. | 2,333,713 | $8.0M |
| AVTXAvalo Therapeutics, Inc. | 483,000 | $7.2M |
| LONALeonaBio, Inc. | 464,398 | $4.8M |
| RLMDRELMADA THERAPEUTICS, INC. | 633,901 | $4.4M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.